Research Grants
CurePSP Research Grants fund innovative research into the biology, biomarkers, and treatment of Progressive Supranuclear Palsy and Corticobasal Degeneration.
Funder: CurePSP
Due Dates: December 15, 2025 (Letter of Intent, Biomarker Accelerator Program) | October 15, 2026 (Full application, CurePSP New Investigator Award)
Funding Amounts: Up to $100,000 per award for 1–2 years (New Investigator Award); see program guidelines for specific mechanisms.
Summary: Supports research advancing the understanding and treatment of Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD), with emphasis on neurobiology, biomarkers, and therapeutics.
Description
CurePSP offers research grants to support scientific and translational projects that deepen understanding of the biology, mechanisms, and treatment of Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD). The grants aim to accelerate discoveries in areas such as tau biology, neuroinflammation, synaptic dysfunction, biomarker development, and drug discovery. The program funds both fundamental research and translational studies, with specific opportunities for early career investigators through the New Investigator Award and for biomarker research through the Biomarker Accelerator Program.
